Leah Zoe Gibson Rand (Leah Z Rand, Leah Rand, Leah Z G Rand)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Venues

Health services research

Clinical pharmacology and therapeutics

Journal of the American Geriatrics Society

Health economics, policy, and law

Brigham and Women's Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Brigham and Women's Hospital

United States

Postdoctoral Fellow :: Program on Regulation, Therapeutics, and Law (PORTAL)

Publications

Leah Zoe Gibson Rand, Sarah McGraw, Junyi Wang, Steven Woloshin, Shirley V Wang, Jonathan J Darrow, Aaron S Kesselheim
Patient perspectives on evidence supporting drug safety and effectiveness: "What does it mean for me?" Journal of the American Geriatrics Society 72 (9) (2024)
William B Feldman, Leah Zoe Gibson Rand, Daniel Carpenter, Massimiliano Russo, Anushka Bhaskar, Zhigang Lu, Eric G Campbell, Jonathan Darrow, Aaron S Kesselheim
Trust in the Food and Drug Administration: A National Survey Study. Clinical pharmacology and therapeutics 116 (2) (2024)
William B Feldman, Leah Zoe Gibson Rand, Daniel Carpenter, Massimiliano Russo, Anushka Bhaskar, Zhigang Lu, Eric G Campbell, Jonathan Darrow, Aaron S Kesselheim
Trust in the Food and Drug Administration: A National Survey Study. Clinical pharmacology and therapeutics 116 (2) (2024)
William B Feldman, Leah Zoe Gibson Rand, Daniel Carpenter, Massimiliano Russo, Anushka Bhaskar, Zhigang Lu, Eric G Campbell, Jonathan Darrow, Aaron S Kesselheim
Trust in the Food and Drug Administration: A National Survey Study. Clinical pharmacology and therapeutics (2024)
Leah Zoe Gibson Rand, Sarah McGraw, Junyi Wang, Steven Woloshin, Shirley V Wang, Jonathan J Darrow, Aaron S Kesselheim
Patient perspectives on evidence supporting drug safety and effectiveness: "What does it mean for me?" Journal of the American Geriatrics Society (2024)
William B Feldman, Leah Zoe Gibson Rand, Daniel Carpenter, Massimiliano Russo, Anushka Bhaskar, Zhigang Lu, Eric G Campbell, Jonathan Darrow, Aaron S Kesselheim
Trust in the Food and Drug Administration: A National Survey Study. Clinical pharmacology and therapeutics 116 (2) (2024)
Leah Zoe Gibson Rand, Sarah McGraw, Junyi Wang, Steven Woloshin, Shirley V Wang, Jonathan J Darrow, Aaron S Kesselheim
Patient perspectives on evidence supporting drug safety and effectiveness: "What does it mean for me?" Journal of the American Geriatrics Society 72 (9) (2024)
Victoria Charlton, Michael J DiStefano, Polly Mitchell, Liz Morrell, Leah Zoe Gibson Rand, Gabriele Badano, Rachel Mairi Baker, Michael Calnan, Kalipso Chalkidou, Anthony J Culyer, Daniel Howdon, Dyfrig A Hughes, James Lomas, Catherine Max, Christopher McCabe, James F O'Mahony, Mike Paulden, Zack Pemberton-Whiteley, Annette Rid, Paul A Scuffham, Mark J Sculpher, Koonal Kirit Shah, Albert Weale, Gry Wester
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment. Health economics, policy, and law (2023)
Leah Zoe Gibson Rand, Aaron S Kesselheim
Limitations on the Capability of the FDA to Advise. The American journal of bioethics : AJOB 22 (10) (2022)
Leah Zoe Gibson Rand, G J Melendez-Torres, Aaron S Kesselheim
Alternatives to the quality-adjusted life year: How well do they address common criticisms? Health services research (2022)
Leah Zoe Gibson Rand, G J Melendez-Torres, Aaron S Kesselheim
Alternatives to the quality-adjusted life year: How well do they address common criticisms? Health services research 58 (2) (2022)
Leah Zoe Gibson Rand, Aaron S Kesselheim
Getting the Price Right: Lessons for Medicare Price Negotiation from Peer Countries. PharmacoEconomics 40 (12) (2022)
Leah Zoe Gibson Rand, G J Melendez-Torres, Aaron S Kesselheim
Alternatives to the Quality-Adjusted Life Year: How Well Do They Address Common Criticisms? Health services research (2022)
Leah Zoe Gibson Rand, G J Melendez-Torres, Aaron S Kesselheim
Alternatives to the quality-adjusted life year: How well do they address common criticisms? Health services research 58 (2) (2022)
Leah Zoe Gibson Rand, Aaron S Kesselheim
Performance-Linked Reimbursement and the Uncertainty of Novel Drugs. Circulation. Cardiovascular quality and outcomes 15 (1) (2022)
Leah Zoe Gibson Rand, Aaron S Kesselheim
Payments for research participation: Don't tax the Guinea pig. Clinical trials (London, England) 19 (5) (2022)
Leah Zoe Gibson Rand, G J Melendez-Torres, Aaron S Kesselheim
Alternatives to the quality-adjusted life year: How well do they address common criticisms? Health services research 58 (2) (2022)
Gry Wester, Leah Zoe Gibson Rand, Christine Lu, Mark Sheehan
The ethics of grandfather clauses in healthcare resource allocation. Bioethics 35 (2) (2020)

Leah Zoe Gibson Rand.css-eqlu8i{font-size:small;padding-left:4px;} (Leah Z Rand, Leah Rand, Leah Z G Rand)

Publication Activity (10 Years)

Top Topics

Top Venues

Leah Zoe Gibson Rand (Leah Z Rand, Leah Rand, Leah Z G Rand)